Influence of MMP-2 and MMP-9 promoter polymorphisms on gene expression and clinical outcome of non-small cell lung cancer

被引:92
|
作者
Rollin, Jerome
Regina, Sandra
Vourc'h, Patrick
Iochmann, Sophie
Blechet, Claire
Reverdiau, Pascale
Gruel, Yves
机构
[1] Fac Med Tours, INSERM, U618, F-37032 Tours, France
[2] IFR 135, F-37000 Tours, France
[3] INSERM, U619, F-37000 Tours, France
关键词
MMP-2; MMP-9; TFPI-2; non-small cell lung cancer; polymorphism; gene expression; prognosis;
D O I
10.1016/j.lungcan.2006.11.021
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Matrix metalloproteinases (MMP) including MMP-2 and MMP-9 play a major role in tumour invasion by proteolysing the extracellular matrix. Their activation, particularly that of MMP-9, is partly dependent on plasmin that is inhibited by TFPI-2 (tissue factor pathway inhibitor-2), a serine protease inhibitor whose gene expression is decreased in about one-third of non-small cell lung cancers (NSCLC). In addition, MMP-2 and MMP-9 are essential in the development of NSCLC and can be regulated by functional promoter polymorphisms. In this study, the -1306C/T MMP-2, -735C/T MMP-2 and -1562C/T MMP-9 polymorphisms were analysed in 90 NSCLC patients and 90 controls. In addition, the promoter region of the TFPI-2 gene was screened for sequence variations in both groups by DHPLC. A -167G/A polymorphism was identified in 3% of controls whereas none of the 90 patients exhibited this genetic variation in the TFPI-2 promoter region. Moreover, no difference in -1306C/T MMP-2, -735C/T MMP-2 and -1562C/T MMP-9 genotypes was found between cases and controls. However, the homozygous -1562CC MMP-9 genotype was more frequent in patients with squamous cell carcinoma than in controls (p=0.018). When genotype distributions were compared to MMP-2 and MMP-9 gene expression in tumours, no relationship was found with the -1306 MMP-2 and -1562 MMP-9 polymorphisms. In contrast, tumour MMP-2 gene expression was tower in homozygous -735CC patients than in those with CT or TT genotypes. In addition, the survival time was longer in patients with the MMP-2 -735T allele than in those with the CC genotype (p = 0.02). The relative risk of death was increased 2.6-fold in -735CC patients (p = 0.045; 95% CI = 1.0-6.7). The results of this study suggest that the -735C/T MMP-2 polymorphism might be an independent prognostic marker in NSCLC, but this should be confirmed in a larger cohort of patients. (c) 2006 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:273 / 280
页数:8
相关论文
共 50 条
  • [31] Functional polymorphisms in the promoter region of MMP-2 and MMP-9 and susceptibility to obstructive sleep apnea
    Chao Cao
    Bin Wu
    Yanping Wu
    Yiming Yu
    Hongying Ma
    Shifang Sun
    Qiaoli Zhang
    Qunli Ding
    Li Chen
    Zaichun Deng
    Scientific Reports, 5
  • [32] Mmp-2 And Mmp-9 Promoter Polymorphisms And Pleural Gelatinase Activity In The Patients With Pleural Effusions
    Liu, F. -C.
    Hsieh, W. -Y.
    Hung, Y. -H.
    Chen, M. -Y.
    Wu, C. -L.
    Yeh, F. -Y.
    Lin, C. -S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [33] Gene Polymorphisms and Circulating Levels of MMP-2 and MMP-9: A Review of Their Role in Breast Cancer Risk
    Dofara, Suelene Georgina
    Chang, Sue-Ling
    Diorio, Caroline
    ANTICANCER RESEARCH, 2020, 40 (07) : 3619 - 3631
  • [34] Clinical and functional significance of TNF-α, MMP-2 and MMP-9 gene promoter single nucleotide polymorphisms in inflammatory bowel disease
    Meijer, MJW
    Mieremet-Ooms, MAC
    van Duijn, W
    van Hogezand, RA
    Lamers, CBHW
    Verspaget, HW
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2005, 17 (01) : A59 - A60
  • [35] The value of MMP-9 for breast and non-small cell lung cancer patients' survival
    Schveigert, D.
    Cicenas, S.
    Bruzas, S.
    Samalavicius, N. E.
    Gudleviciene, Z.
    Didziapetriene, J.
    ADVANCES IN MEDICAL SCIENCES, 2013, 58 (01): : 73 - 82
  • [36] Activities and polymorphisms of MMP-2 and MMP-9, smoking, diabetes and risk of prostate cancer
    Kiani, Amir
    Kamankesh, Marjan
    Vaisi-Raygani, Asad
    Moradi, Mahmoud-Reza
    Tanhapour, Maryam
    Rahimi, Zohreh
    Elahi-Rad, Saeed
    Bahrehmand, Fariborz
    Aliyari, Mahdieh
    Aghaz, Faranak
    Mozafari, Hadi
    Rezvani, Nayebali
    Haghnazari, Lida
    Pourmotabbed, Tayebeh
    MOLECULAR BIOLOGY REPORTS, 2020, 47 (12) : 9373 - 9383
  • [37] Activities and polymorphisms of MMP-2 and MMP-9, smoking, diabetes and risk of prostate cancer
    Amir Kiani
    Marjan Kamankesh
    Asad Vaisi-Raygani
    Mahmoud-Reza Moradi
    Maryam Tanhapour
    Zohreh Rahimi
    Saeed Elahi-Rad
    Fariborz Bahrehmand
    Mahdieh Aliyari
    Faranak Aghaz
    Hadi Mozafari
    Nayebali Rezvani
    Lida Haghnazari
    Tayebeh Pourmotabbed
    Molecular Biology Reports, 2020, 47 : 9373 - 9383
  • [38] Matrix metalloproteinase (MMP-9 and MMP-2) gene polymorphisms influence allograft survival in renal transplant recipients
    Singh, Ranjana
    Srivastava, Priyanka
    Srivastava, Aneesh
    Mittal, Rama Devi
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2010, 25 (10) : 3393 - 3401
  • [39] Increased expression of gelatinases (MMP-2 & MMP-9) in human colorectal cancer
    Keh, C
    Ismail, T
    de Takats, PG
    Martin, A
    Wakelam, MJO
    Kerr, DJ
    BRITISH JOURNAL OF CANCER, 1998, 78 : 15 - 15
  • [40] Expression of metalloproteinases (MMP-2 and MMP-9) in basal-cell carcinoma
    Anna Goździalska
    Anna Wojas-Pelc
    Jagoda Drąg
    Paweł Brzewski
    Jerzy Jaśkiewicz
    Maciej Pastuszczak
    Molecular Biology Reports, 2016, 43 : 1027 - 1033